Title : A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease - Nakamura_2015_Dement.Geriatr.Cogn.Dis.Extra_5_361